US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

628.26

-1.3457-0.21%

Number of Gainers:2

Number of Losers:2

Number of Flat:- -

PE:- -

High:638.39

Open:630.08

Low:627.23

Close:629.61

Volume:13.78M

Turnover:317.93M

Market Cap:19.90B

Float Cap:15.47B

Loading ...

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

Tempus AI CEO Lefkofsky to Speak at Morgan Stanley Global Healthcare Conference

The Cancer Vaccine Gold Rush Has Begun. so Has the Race for Picks and Shovels - Heard on the Street

Tempus AI Director David R. Epstein Sells 250 Shares Worth $16,387.50

CRISPR Therapeutics (CRSP) Extends CTX310 Durability, Is The Stock Still Cheap?

Simply Wall St.

Recursion Pharma Director Blake Borgeson Disposes of 30,000 Shares Valued at $100,200

Top AI Healthcare Stocks For September 2026

Simply Wall St.

Tempus AI initiated with an Overweight at Cantor Fitzgerald

Tempus AI Director Nadja West Sells 3,000 Shares Worth $207,000

Investors Shrug Off Good News for Heart Patients from New Meds

Tempus AI Raised to Overweight from Neutral by Piper Sandler

Tempus AI Shares up 3% After Piper Sandler Raises to Overweight from Neutral

THOMSON REUTERS

Press Release: Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer

Piper Sandler Upgrades Tempus AI to Overweight From Neutral, Adjusts PT to $76 From $56

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB)

Tempus AI, Inc. : Piper Sandler Raises to Overweight from Neutral; Raises Target Price to $76 from $56

THOMSON REUTERS

Liontown Resources Executes Farm-In Agreement for Argentina Lithium Brine Project

MT Newswires Live

Tempus AI is Maintained at Hold by Freedom Capital Markets

Tempus AI (TEM) Could Be 18% Below Fair Value As FDA Clearance Lands

Simply Wall St.

CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK4611/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":628.2648,"timestamp":1789156799999,"preClose":629.6105,"halted":0,"volume":13776673,"delay":0,"changeRate":-0.002137,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-1.345703,"latestTime":"09-11 16:00:00 EDT","open":630.0837,"high":638.3864,"low":627.2322,"amount":317931521.23481,"amplitude":0.017716,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.739347,"peRate":-15.089385,"turnoverRate":0.016758,"increases":2,"decrements":2,"flats":0,"marketCap":19904441344,"floatMarketCap":15473712256},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":638.3864,"amplitude":0.017716,"preClose":629.6105,"low":627.2322,"pbRate":"4.739347","latestPrice":628.2648,"volume":13776673,"delay":0,"open":630.0837,"prevYearClose":658.3995,"prevWeekClose":700.621,"prevMonthClose":691.9381,"prevQuarterClose":681.0329,"fiveDayClose":698.548,"twentyDayClose":625.3489,"sixtyDayClose":615.9527,"secType":"PLATE","market":"US","turnoverRate":0.016758,"peRate":-15.089385,"marketCap":19904441344,"floatMarketCap":15473712256,"timestamp":1789156799999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":2,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665432460","title":"Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432460","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665432460?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:00","pubTimestamp":1788861600,"startTime":"0","endTime":"0","summary":"BEAM-302 Continues to Demonstrate Potential as One-time Treatment for Both Lung and Liver Manifestations of AATD, with AAT Protein Production Under Normal Physiological Control With Up to 18 Months Fo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357432/0/en/beam-therapeutics-presents-updated-clinical-data-from-the-phase-1-2-trial-of-beam-302-in-alpha-1-antitrypsin-deficiency-aatd-at-the-european-respiratory-society-ers-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PRTO","BEAM","BK4139","LU1861559042.SGD","BK4535","BK4599","LU1878469433.USD","IDNA","BK4588","LENZ","EPV","BK4556","BK4007","BK4505","BK4539","ALT","LU1861558580.USD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334854","title":"Tempus AI CEO Lefkofsky to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334854","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334854?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:30","pubTimestamp":1788525028,"startTime":"0","endTime":"0","summary":"Tempus AI CEO Lefkofsky to speak at Morgan Stanley Global Healthcare ConferenceTempus AI CEO Eric Lefkofsky will join a fireside chat at Morgan Stanley’s 24th Annual Global Healthcare Conference on Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL5LrmbK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMC","TEMT","LU1861558580.USD","LU1861559042.SGD","BK4611","HEAL","BK4613","BK4121","ARKG","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333870","title":"The Cancer Vaccine Gold Rush Has Begun. so Has the Race for Picks and Shovels - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333870","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664333870?lang=en_us&edition=fundamental","pubTime":"2026-09-04 17:30","pubTimestamp":1788514200,"startTime":"0","endTime":"0","summary":"The excitement surrounding Moderna and Merck's personalized mRNA cancer vaccine added more than $50 billion in combined market value for the two drug companies. But it is also creating a gold rush in ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","TEMT","ARKG","LU1861558580.USD","LU1861559042.SGD","BK4611","TEMC","BK4121","BK4613","HEAL","PSNL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809740","title":"Tempus AI Director David R. Epstein Sells 250 Shares Worth $16,387.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809740","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809740?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:06","pubTimestamp":1788465961,"startTime":"0","endTime":"0","summary":"Tempus AI director David R. Epstein sells 250 shares worth $16,387.50Tempus AI director David R. Epstein sold 250 shares of Class A common stock on Sept. 1, 2026 at USD 65.55.He held 30,844 shares fol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1WGVhM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI Director David R. Epstein Sells 250 Shares Worth $16,387.50","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","TEM","TEMC","LU1861559042.SGD","BK4121","TEMT","ARKG","HEAL","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664826961","title":"CRISPR Therapeutics (CRSP) Extends CTX310 Durability, Is The Stock Still Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664826961","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664826961?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:26","pubTimestamp":1788402388,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (CRSP) is back in focus after new Phase 1a durability data for CTX310, its in vivo ANGPTL3 gene editing therapy, highlighted sustained lipid reductions one year after a single infusion.\nAt a share price of $56.92, CRISPR Therapeutics has had a mixed year, with a 30 day share price return of 14.83% and a year to date share price return of 5.86%, while the 1 year total shareholder return of 7.44% suggests that momentum has been improving recently as investors react to the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-extends-ctx310-durability-is-the-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-extends-ctx310-durability-is-the-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1861559042.SGD","BK4585","LU1861558580.USD","BK4139","BK4611","BK4588","SYNB","BK4556","DCF","SPHQ","CRSP","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664423048","title":"Recursion Pharma Director Blake Borgeson Disposes of 30,000 Shares Valued at $100,200","url":"https://stock-news.laohu8.com/highlight/detail?id=2664423048","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664423048?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:27","pubTimestamp":1788391639,"startTime":"0","endTime":"0","summary":"Recursion Pharma director Blake Borgeson disposes of 30,000 shares valued at $100,200Recursion Pharmaceuticals director Blake Borgeson sold 30,000 Class A common shares on Sept. 1, 2026 at $3.34.Direc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbkJccF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharma Director Blake Borgeson Disposes of 30,000 Shares Valued at $100,200","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4539","BK4139","BK4609","BK4548","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843951","title":"Top AI Healthcare Stocks For September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843951","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843951?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:20","pubTimestamp":1788362427,"startTime":"0","endTime":"0","summary":"Oil prices linked to US Iran risks are feeding into higher inflation expectations and government bond yields. That puts pressure on healthcare budgets and insurance costs, which makes smarter, more efficient care especially valuable. Artificial intelligence in healthcare targets that problem by using data, automation and remote monitoring to do more with less. This article walks through 3 stocks from our AI healthcare screener that illustrate how that theme is playing out.\nThe three stocks...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/top-ai-healthcare-stocks-for-september-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/top-ai-healthcare-stocks-for-september-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0306807586.USD","IE00B3T34201.USD","SG9999003800.SGD","LU0868494617.USD","OZEM","PFE","LU2271345857.HKD","LU1571399168.USD","LU0170899867.USD","LU1861559042.SGD","LU0225771236.USD","IE0002270589.USD","LU1894683348.USD","IE00BVYPNV92.GBP","LU1989771016.USD","LU1244550577.SGD","BK4007","LU2023251221.USD","LU1506573853.SGD","LU1057294990.SGD","LU0211331839.USD","LU1244550494.USD","LU0496365809.HKD","LU0456855351.SGD","LU1244550221.USD","LU0122379950.USD","LU0306806265.USD","LU1066051498.USD","LU1061106388.HKD","LU2089283258.USD","SG9999002224.SGD","SG9999001176.USD","IE00BVYPNW00.USD","LU2089284900.SGD","SG9999011175.SGD","SG9999002232.USD","SG9999001176.SGD","BK4581","ARKG","LU0225284248.USD","LU1883839398.USD","BK4534","LU1116320901.HKD","LU0070302665.USD","LU1894683264.USD","LU0106261372.USD","LU0234572021.USD","LU1861558580.USD","LU0432979614.USD","IE00BGHQF631.EUR","BK4121","IE00BFXG1179.USD","LU0162691827.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","LU0211326839.USD","IE00BLSP4239.USD","LU0072461881.USD","LU2112291526.USD","LU2089984988.USD","LU0265550359.USD","BK4585","IE00BLSP4452.SGD","LU1023059063.AUD","IE00BQXX3D17.EUR","IE00BDGV0183.EUR","BK4568","BK4611","LU0320765489.SGD","LU0006306889.USD","LU0265550946.USD","BK4566","LU2468319806.SGD","LU1983299246.USD","BK4533","LU0058720904.USD","BK4613","LU0211326755.USD","IE00B42XCP33.USD","LU1291159041.SGD","LU0314106906.USD","IE000M9KFDE8.USD","BK4550","LU0158827948.USD","LU0976567544.SGD","IE00BQXX3C00.GBP","HEAL","LU1066053197.SGD","BK4599","LU0321505439.SGD","LU0289739699.SGD","IE00BQXX3F31.USD","LU1116320737.USD","SG9999013999.USD","TEMC","TEMT","LU1989764748.USD","TEM","LU0208291251.USD","LU0158827781.USD","LU1989764664.SGD","BK4082","IE00BBT3K403.USD","LU2028103732.USD","IE00B19Z3B42.SGD","MDT","BK4592","LU0321505868.SGD","LU2596442595.SGD","BK4588","LU0985481810.HKD","LU2111349929.HKD","IE00B3PB1722.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813511","title":"Tempus AI initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813511?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:10","pubTimestamp":1788343813,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald initiated coverage of Tempus AI (TEM) with an Overweight rating and $80 price target Published first on TheFly – the ultimate sou...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEMC","HEAL","LU1861558580.USD","TEM","BK4613","ARKG","BK4611","BK4121","TEMT","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869837","title":"Tempus AI Director Nadja West Sells 3,000 Shares Worth $207,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869837","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869837?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:16","pubTimestamp":1788293761,"startTime":"0","endTime":"0","summary":"Tempus AI director Nadja West sells 3,000 shares worth $207,000Tempus AI director Nadja West sold 3,000 shares of Class A common stock on Aug. 28, 2026.Sale priced at USD 69 per share.West held 31,981","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL7Zft1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI Director Nadja West Sells 3,000 Shares Worth $207,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","TEMT","BK4121","ARKG","LU1861558580.USD","BK4611","LU1861559042.SGD","BK4613","HEAL","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866385","title":"Investors Shrug Off Good News for Heart Patients from New Meds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866385","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866385?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:27","pubTimestamp":1788290820,"startTime":"0","endTime":"0","summary":"This year's run in drug stocks gained vigor from new treatments for heart attacks and strokes. Maybe some of those stocks are losing wind.At this past weekend's congress of the European Society of Car","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BBH","BIB","LU2468319806.SGD","AMGN","BK4611","BK4588","IBBQ","LU0320765992.SGD","LU2112291526.USD","LU1061106388.HKD","LU2242652126.USD","LU1861559042.SGD","BK4585","IE0002141913.USD","BK4139","LU2242646821.SGD","PJP","BK4566","IE0009355771.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","ARKG","LU0289739699.SGD","LU2089984988.USD","BK4599","LU0122379950.USD","IBB","ISBC","LU0868494617.USD","LU0889565916.HKD","LU1023059063.AUD","LU1057294990.SGD","LU1571399168.USD","BK4533","LU1983299246.USD","LU1861558580.USD","BK4534","BK4556","IE00B4R5TH58.HKD","TBXU","CRSP","BK4581","PBE","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664868767","title":"Tempus AI Raised to Overweight from Neutral by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2664868767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664868767?lang=en_us&edition=fundamental","pubTime":"2026-09-02 00:58","pubTimestamp":1788281880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","TEM","TEMC","LU1861559042.SGD","BK4121","TEMT","ARKG","HEAL","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854953","title":"Tempus AI Shares up 3% After Piper Sandler Raises to Overweight from Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854953?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:35","pubTimestamp":1788269741,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T19R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","BK4611","LU1861558580.USD","TEMT","TEM","BK4121","TEMC","HEAL","BK4613","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853155","title":"Press Release: Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853155","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853155?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the app","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4505","BK4588","LU1861558580.USD","LU1861559042.SGD","BK4556","BEAM","BK4539","LENZ","BK4585","BK4007","BK4139","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664085891","title":"Piper Sandler Upgrades Tempus AI to Overweight From Neutral, Adjusts PT to $76 From $56","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664085891?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:22","pubTimestamp":1788258126,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $65.79, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEM","BK4611","LU1861558580.USD","ARKG","BK4613","TEMC","TEMT","BK4121","LU1861559042.SGD","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837781","title":"Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837781","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837781?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:20","pubTimestamp":1788254408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tempus AI, Inc. Class A (TEM) and Assembly Bioscienc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tempus-ai-inc-class-a-tem-and-assembly-biosciences-asmb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tempus-ai-inc-class-a-tem-and-assembly-biosciences-asmb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ASMB","BK4611","TEMC","LU1861558580.USD","BK4613","ARKG","TEM","HEAL","TEMT","LU1861559042.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664744839","title":"Tempus AI, Inc. : Piper Sandler Raises to Overweight from Neutral; Raises Target Price to $76 from $56","url":"https://stock-news.laohu8.com/highlight/detail?id=2664744839","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664744839?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:33","pubTimestamp":1788248000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMT","BK4613","ARKG","TEMC","LU1861558580.USD","TEM","LU1861559042.SGD","BK4121","BK4611","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664889800","title":"Liontown Resources Executes Farm-In Agreement for Argentina Lithium Brine Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2664889800","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664889800?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:56","pubTimestamp":1788220600,"startTime":"0","endTime":"0","summary":"Liontown Resources  executed a binding farm-in agreement with Next Lithium to earn up to a 100% interest in the Centenario lithium brine exploration project in Argentina, with initial consideration comprising about AU$7 million cash and about AU$14 million in Liontown shares payable on initial completion, according to a Tuesday Australian bourse filing.The company said the farm-in structure allows Liontown to progressively increase its interest to 100% by funding about AU$56 million of project expenditure over four years, plus milestone payments of up to about AU$195 million in cash, Liontown shares or a combination at Next Lithium's election.An initial $15 million work program is planned over the first 12 to 24 months, including a drilling campaign targeting anomalies identified by a transient electromagnetic  survey already completed across the project, with Liontown able to earn an effective 49% interest in the project upon funding $15 million in project expenditure within 24 months","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","ARKG","BK4121","HEAL","BK7504","TEM.AU","LIT","LU1861558580.USD","TEMC","BK7095","LU1861559042.SGD","BK4585","SETM","LTR.AU","BK4613","TEMT","TEM","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663844003","title":"Tempus AI is Maintained at Hold by Freedom Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2663844003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663844003?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:20","pubTimestamp":1788178800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","BK4121","BK4611","TEMT","ARKG","LU1861558580.USD","BK4613","TEMC","HEAL","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044562","title":"Tempus AI (TEM) Could Be 18% Below Fair Value As FDA Clearance Lands","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044562","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044562?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:20","pubTimestamp":1788088855,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) shares are drawing attention after the company received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, its AI software for detecting pulmonary hypertension from standard ECGs.\nThe FDA news lands after a volatile stretch for Tempus AI, with the share price down 9.41% over the past day and 11.90% over the past week, yet still posting a 45.98% 30 day share price return and a 21.29% 90 day share price return. The 1 year total shareholder return is...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-could-be-18-below-fair-value-as-fda-clearance","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-could-be-18-below-fair-value-as-fda-clearance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TEMC","HEAL","BK4611","BK4121","TEM","LU1861558580.USD","TEMT","ARKG","BK4613","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663457750","title":"CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2663457750","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663457750?lang=en_us&edition=fundamental","pubTime":"2026-08-30 11:25","pubTimestamp":1788060309,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics stock has had a strong shorter term recovery, yet longer term holders are still sitting on a large loss, and current valuation checks lean more toward an expensive reading than a clear bargain.\n\nThe share price is down about 52.7% over 5 years, which means many longer term investors are still under water even after more recent gains.\nFresh Phase 1a data for CTX310 presented at the ESC Congress 2026 may support confidence in CRISPR Therapeutics drug pipeline, while clinical...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-stock-may-look-rich-following-fresh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-stock-may-look-rich-following-fresh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARKG","BK4588","LU1861559042.SGD","LU1861558580.USD","SYNB","BK4556","BK4611","CRSP","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}]}}